Diadema Partners’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-240,600
Closed -$6.33M 213
2025
Q4
$6.33M Buy
240,600
+44,100
+22% +$962K 1.09% 28
2025
Q3
$3.36M Buy
196,500
+17,200
+10% +$246K 0.86% 42
2025
Q2
$2.25M Hold
179,300
0.69% 39
2025
Q1
$2.14M Buy
+179,300
New +$2.45M 0.56% 43

Other funds holding ZYME

Diadema Partners's ZYME Position: Q2 2026 in Review

Diadema Partners held its Zymeworks (ZYME) position steady in Q2 2026 at 142,132 shares worth $3.72M. The position accounts for 0.47% of the portfolio, ranked #54.

Diadema Partners first reported a position in ZYME in Q1 2026 and has held it in 2 quarters since. 203 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • Diadema Partners held 142,132 shares of Zymeworks worth $3.72M as of Q2 2026.
  • Diadema Partners left its Zymeworks share count unchanged in Q2 2026.
  • Zymeworks made up 0.47% of Diadema Partners's portfolio in Q2 2026, its #54 holding.
  • Diadema Partners first reported a position in Zymeworks in Q1 2026 and has held it in 2 quarters since.
  • 203 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on Diadema Partners's 13F filing for Q2 2026, filed 14 Aug 2026.